Heart and Stroke Lifesavers from Mount Sinai Honored at the American Heart Association 2014 New York City Heart Ball
June 27, 2014
AHA Heart and Stroke Lifesavers are Stephan A. Mayer, MD, FCCM, Director of the Institute for Critical Care Medicine and Beth Oliver, DNP, RN, Vice President of Cardiac Services.
Susan B. Bressman, MD, Honored as "National Physician of the Year" By Castle Connolly Medical, Ltd., Publisher of the Annual America's Top Doctors® Guides
April 1, 2014
Dr. Bressman was recognized at the Ninth Annual Castle Connolly Medical Ltd. National Physician of the Year Awards on March 31.
Icahn School of Medicine at Mount Sinai Named to New NIH Stroke Research Network
December 20, 2013
Research collaborative network aims to expedite stroke clinical trials, build greater expertise in stroke.
The Mount Sinai Medical Center Recognized by U.S. News and World Report in Annual “Best Hospitals” Rankings
July 16, 2013
The Mount Sinai Medical Center is prominently featured in U.S. News & World Report’s clinical specialty ranking of the nation’s most outstanding hospitals.
The Mount Sinai Medical Center Awarded Advanced Certification as Comprehensive Stroke Center by The Joint Commission
July 12, 2013
Mount Sinai is the first hospital in New York State to receive The Joint Commission Comprehensive Stroke Center certification.
Mount Sinai Experts Call for Research on Prevalence of Delayed Neurological Dysfunction After Head Injury
April 5, 2013
Preventive measures, genetic risks, new diagnostic tools needed to identify effects of traumatic brain injury in athletes, soldiers.
Mount Sinai Leads Global Program Using Stem Cells to Accelerate Cures for Alzheimer's Disease
March 27, 2013
Researchers collaborate with the New York Stem Cell Foundation using skin samples and brain imaging to identify causes and cures.
New Drug Is Safe and Effective in Reducing 'Off' Time in People with Parkinson's Disease
March 21, 2013
New research in Parkinson's disease and Alzheimer's disease were presented at the American Academy of Neurology meeting this week.
Combination Therapy Provides Similar Clinical Benefit as Single Drug Treatment in People with MS
March 11, 2013
Drugs taken together do not reduce risk of relapse but appear to prevent development of new lesions
Facts about How Mount Sinai is Researching and Treating Brain Diseases
December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases.
Changes in Nerve Cells Caused by Social Isolation May Contribute to the Development of Mental Illness
November 11, 2012
Reduced production of myelin, a type of nerve fiber that is lost in diseases like MS, may also play a role in the development of mental illness.
The Nest - Personalities for Being a Doctor
October 29, 2012
Dr. Stuart Sealfon, professor and chair of the neurology department at Mount Sinai School of Medicine discusses some of the personality traits successful doctors possess.
Anti-Cancer Activity Drug IRX4204 Shows Promise as a Potential Disease-Modifying Agent for Alzheimer’s Disease
September 13, 2012
Giulio Pasinetti, MD, PhD, presented research at 6th Neurodegenerative Conditions Research and Development Conference.
Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice
August 8, 2012
Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease
Migraine Medication May Be Safe in Pregnant Women
June 22, 2012
Mount Sinai researchers find that a preventive therapy for migraine has little to no increased risk for birth defects in pregnant women.
Grape-Derived Compound Prevents Alzheimer's Disease Progression in Mice
May 2, 2012
Mount Sinai researchers harnessed the beneficial effects of grape-seed extract on the brain and developed a biosynthetic compound that improves cognition in mice.
Researchers Gain Better Understanding of the Mechanism Behind Alzheimer's Disease Progression
May 1, 2012
Mount Sinai scientists have determined how a pathological brain protein called tau contributes to the progression of Alzheimer's disease.
Decaffeinated Coffee Improves Brain Energy Metabolism in an Animal Study
February 2, 2012
Mount Sinai researchers have found that decaffeinated coffee may reduce impaired brain energy metabolism associated with type 2 diabetes, a known risk factor for neurocognitive disorders.
The Mount Sinai Stroke Center Receives "Get with the Guidelines Stroke Silver Plus Quality" Achievement Award
January 18, 2012
Award Demonstrates Mount Sinai’s Commitment to Quality Care for Stroke Patients
Researchers Discover Clues to Developing More Effective Antipsychotic Drugs
November 23, 2011
Mount Sinai has identified the pattern of cell signaling induced by antipsychotic drugs in a complex composed of two brain receptors linked to schizophrenia.
New Mount Sinai Study Shows How to Eliminate Motion Sickness on Tilting Trains
August 4, 2011
Researchers found that adjusting the timing of when the train cars tilt as they enter and leave the curves can essentially eliminate motion sickness.
Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s
July 18, 2011
Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease.
A Natural Chemical Found in Grape Seeds May Prevent Development or Progression of Alzheimer’s
July 15, 2011
Mount Sinai researchers found that polyphenols, a natural extract found in grapes, may help prevent or treat Alzheimer’s disease.
New Research Shows the Aging Brain Does Not Respond To Experience As Well as the Younger Brain
May 24, 2011
Mount Sinai researchers have found reduced ability of the aging brain to learn and respond to experiences, a finding that sheds new light on the aging process.
Mount Sinai Researchers Help Identify Differences in Disease Progression in Two Subtypes of MS
April 14, 2011
New data from the American Academy of Neurology meeting describes the consequences of relapses in MS patients who initially have a progressive course.
Indications of Alzheimer’s Disease May Be Evident Decades Before First Signs of Cognitive Impairment
March 28, 2011
Mount Sinai Researchers find a link between lower glucose utilization in the brain and Alzheimer’s disease.
Mount Sinai Researchers Uncover How a Gene Mutation Causes Parkinson’s Disease
March 25, 2011
The new finding explains how mutations lead to the development of the most common form of Parkinson’s, providing a new diagnostic and drug target for the disease.
Mount Sinai Launches Neuroimaging Study to Understand Brain Changes in Alzheimer’s Disease
March 8, 2011
Funded by the NIH, the study will use imaging techniques and biomarkers to understand changes in the structure and function of the brain.
Researchers Find Star-Shaped Brain Cell That Support Neurons Also Aid in Formation of Long-Term Memories
March 4, 2011
Lactate, which is energy fuel produced in a type of brain cell called an astrocyte, plays a critical role in long-term memory formation.
Four Mount Sinai Researchers Awarded Prestigious "Young Investigator Grant" for Their Brain and Behavior Research
February 18, 2011
The National Alliance for Research on Schizophrenia and Depression awarded the $60,000 grants to enable the scientists to continue their work.
Mount Sinai’s Burton Drayer, MD, Elected President of the Radiological Society of North America
January 31, 2011
Dr. Drayer, Chair of the Department of Radiology, has been elected president of the society’s board of directors.
Dystonia Expert Steven Frucht, MD Appointed Director of the Movement Disorders Division
January 24, 2011
Dr. Frucht, a renowned expert in hyperkinetic disorders, joins the Robert and John M. Bendheim Parkinson and Movement Disorders Center.
Mount Sinai School of Medicine Receives $17 Million from NIH To Study Patterns of Flu Infection
December 15, 2010
NIH renews Program for Research on Immune Modeling and Experimentation funding to develop math models to better predict patterns of flu infection.
Health Resources and Services Administration Honors Dr. Jennifer Frontera As Organ Donation Champion
November 10, 2010
The HRSA has recognized Dr. Jennifer Frontera for demonstrating an exceptional commitment to organ donation and transplantation in New York State.
Gene Associated with Type 2 Diabetes Is Low in People with Alzheimer’s Disease
October 12, 2010
A study in the journal Aging Cell shows that people with Alzheimer’s disease have a low level of the gene PGC-1, which regulates glucose.
Mount Sinai Researchers Identify Key Mechanism in Gene Linking Diabetes to Alzheimer’s
September 28, 2010
Dr. Sam Gandy and his team have found that that a gene for a protein that may cause type 2 diabetes impacts the development of Alzheimer’s disease.
Mount Sinai Study Shows That Major Alzheimer’s Risk Gene Causes Alterations in Shapes of Brain Protein Deposits
July 14, 2010
A team led by Dr. Sam Gandy is presenting new research at the Alzheimer's Association International Conference on Alzheimer's Disease
Antihypertensive Drugs May Protect against Alzheimer’s Disease and Promote Healthy Memory
June 24, 2010
Researchers at Mount Sinai School of Medicine have found that a blood pressure drug may lessen the impact of Alzheimer’s disease and promote healthy memory.
Stuart C. Sealfon, MD, Receives NARSAD Distinguished Investigator Award
May 14, 2010
Stuart C. Sealfon, MD, Chairman of the Department of Neurology at Mount Sinai School of Medicine, receives the Distinguished Investigator Grant Award.
Alzheimer’s Memory Problems Originate with Protein Clumps Floating in the Brain, Not Amyloid Plaques
April 27, 2010
Researchers at Mount Sinai School of Medicine have found that Alzheimer’s is not caused by amyloid plaques, as previously thought by many researchers.
Groundbreaking Multiple Sclerosis Research Presented at American Academy of Neurology Annual Meeting
April 13, 2010
Researchers from Mount Sinai School of Medicine will present several studies on multiple sclerosis at the American Academy of Neurology Annual Meeting.
New “Mouse Models” Give Insight to Gene Mutation That Is Potential Cause Of Parkinson’s Disease
March 31, 2010
Mount Sinai School of Medicine researchers are among the first to discover how gene mutations may cause Parkinson’s disease.
The Mount Sinai Medical Center Teams With NFL to Create Neurological Program for Retired Players
March 24, 2010
The NFL has selected The Mount Sinai Medical Center to be part of its new Neurological Care Program (NCP) for retired NFL players.
New Mount Sinai Support Groups Will Address the Needs of Parkinson's and Dystonia Patients and Their Caregivers
January 5, 2010
Mount Sinai launches four new support groups to assist patients with Parkinson's disease and dystonia. Topics of discussion will include nutrition, new therapies, and caregiver needs.
Mount Sinai Researcher Led Study to Determine If Drug Slows Progression of Parkinson's Disease
September 24, 2009
C. Warren Olanow, MD, Professor and Chairman Emeritus, Department of Neurology, led an 18-month study on whether a drug used to treat Parkinson's actually slows disease progression.
Mount Sinai Research Identifies Brain Mechanisms Associated with Borderline Personality Disorder
September 3, 2009
Through real-time imaging, researchers have collected evidence to suggest that neurological networks that help regulate emotion do not activate in patients with borderline personality disorder.
Mount Sinai School of Medicine Significantly Improves Its U.S. News & World Report Best Graduate Schools Rankings
April 24, 2009
Over the past four years, Mount Sinai has improved in the U.S. News & World Report "America's Best Graduate Schools" rankings more than any other school in the United States, jumping from 32nd to 22nd.
Wayne A. Gordon, PhD, Named 2009 Robert L. Moody Prize Recipient
March 13, 2009
Dr. Wayne Gordon has been awarded the 2009 Robert L. Moody Prize for Distinguished Initiatives in Brain Injury Research and Rehabilitation.
New Psychiatric Program at The Mount Sinai Medical Center Addresses Special Needs of Multiple Sclerosis Patients
February 26, 2009
The new program provides for an on-site psychiatrist to assist in the identification and management of psychiatric and psychological disorders in patients with MS, including depression.